Travere Therapeutics
TVTX
TVTX
168 hedge funds and large institutions have $737M invested in Travere Therapeutics in 2023 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
–
Holders Change %
0%
% of All Funds
2.68%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
35
Increased
65
Reduced
49
Closed
34
Calls
$14M
Puts
$20.6M
Net Calls
-$6.54M
Net Calls Change
+$1.3M
Top Buyers
| 1 |
Millennium Management
New York
|
+$24.4M |
| 2 |
VA
VR Adviser
New York
|
+$23.5M |
| 3 |
Morgan Stanley
New York
|
+$12.9M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$11.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$9.93M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$62M |
| 2 |
O
OrbiMed
New York
|
-$32.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.8M |
| 4 |
State Street
Boston,
Massachusetts
|
-$12M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$7.6M |
